Shorts

Why Rheumatologists Are Key to Lung Health: Steven Nathan, MD

What PCSK9 Inhibitors Reveal About Innovation, Access: Deepak Bhatt, MD, MPH, MBA

How Fraudulent Claims Are Inflating ACO Costs: Aisha Pittman, MPH

Expanding the GLP-1 Pipeline for Diabetes Care: Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES

The "Rule of 7" for Remdesivir Treatment: Nitipong Permpalung, MD, MPH

The Surprising Reality of C. Diff in Your Home: Bruce Hirsch, MD

Exploring Tirzepatide’s Potential Cardiovascular Benefits: Deepak Bhatt, MD, MPH, MBA

CD19, a Smart Target With a Trade-Off: Martin Schrappe, MD, PhD

How SkinIO's Full Body Scan Caught Melanoma: Steve Bonner

The Importance of Context When Using Polygenic Risk Scores: David Zhang, MD

How ACOs Uncover Medicare "Mailbox Store" Fraud: Aisha T. Pittman, MPH

Paving the Way to a Myeloma Cure: Ajay K. Nooka, MD, PhD

INCA033989 Marks a Potential Turning Point in Mutant Calreticulin–Positive Myelofibrosis: Claire Harrison, MD

Why BMI Is Misleading for Measuring Cardiometabolic Risk: Deepak Bhatt, MD, MPH, MBA

Translated Financial Assistance Documents Are Critical to Reducing Care Barriers: Erin L. Duffy, PhD, MPH

TED Approval Offers Bright Future for Treating Condition: Michael Yen, MD

Supporting Families Requires Recognizing the Full Financial Impact of Pediatric Cancer: Cherie Daly, MD

Policy, Technology Misalignment Slows NSCLC Genomic Testing: Robert Kratzke, MD

Long-Term Follow-Up Needed to Assess Axatilimab’s Bone Health Effects in Chronic GVHD: Amandeep Salhotra, MD

Human-Centered Approach Needed to Reduce Pediatric Cancer Financial Toxicity: Danielle Fragalla, MSE

The Future of Cell Therapy: Beyond Current Limitations: Muhammad Bilal Abid, MD

Health Plan Policies Can Expand Access to Pharmacy-Based Contraceptive Care: Sally Rafie, PharmD

How the OCM Reshaped Oncology Practice Conversations: Kathy Oubre, MS

Building the Ideal CRM Care Team: Sheng Fu, MD

The Evolution & Risk of Modern Cell Therapy: Muhammad Bilal Abid, MD

Next Steps After Negative Biomarker Testing in NSCLC: Robert Kratzke, MD

Care Management Is the Future of Oncology: Stephen Schleicher, MD, MBA

4 Strategies to Protect Severely Immunocompromised Patients: Muhammad Bilal Abid, MD

The Advent of the OCM: Stephen Schleicher, MD, MBA

Sleep Apnea is Underdiagnosed, But Treatment is Covered: Martin Hopp, MD, PhD